Boston, MA 10/07/2013 (wallstreetpr) – In Friday’s trading, iCAD Inc (NASDAQ:ICAD) rose by 7.21%. The opening price of the shares was $5.95, which climbed to an intraday high of $6.51 and dipped to a close of $6.39. Approximately 0.132 million shares were traded on Friday while an average volume of 0.373 million shares were traded over a 30-day period. The 52-week low of CalAmp Corp (NASDAQ:CAMP) shares is $1.85 and its 52-week high is $6.90. The company has a market capitalization of $69.33 million.
About the company
iCAD Inc (NASDAQ:ICAD) is an advanced image-analysis and workflow-solutions provider that helps healthcare-professionals to serve their patients by identifying pathologies or pinpointing prevalent-cancers earlier. The company offers a variety of upgradeable Computer-Aided Detection systems and workflow-solutions for Magnetic Resonance Imaging, Mammography and Computed Tomography. Its solutions enable numerous radiologists to serve their patients by identifying various pathologies and pinpointing different cancers. Its digital and MRI-CAD products include advanced-image analysis and workflow-solutions in breast-imaging, advanced image-analysis and workflow-solutions in MRI-imaging – prostate and breast and advanced-image analysis and workflow-solutions in CT Colonography.
The products
iCAD Inc (NASDAQ:ICAD)’s Film-based products include converting-mammography films to digital-images. The company’s electronic-brachytherapy products include electronic-brachytherapy treatment for breast-cancer.
The company acquired Xoft, Inc and this deal brought an isotope free cancer-treatment platform technology to its product-line. The company is engaged in designing, developing, manufacturing, marketing and selling electronic-brachytherapy products that are used in the treatment of endometrial, breast and skin cancer as well as in the treatment of various other cancers or some conditions where radiation-therapy is indicated.
The company’s portable Axxent System delivers electronically-controlled radiation therapy straight to cancer-sites with minimal-radiation exposure to the surrounding healthy tissue. This has been cleared by the FDA. Electronic Brachytherapy is a kind of brachytherapy that uses a miniaturized high-dose rate X-ray-source for the application of radiation straight to the cancerous site.
